Investing21d
Earnings call transcript: Marsh McLennan Q4 2024 beats EPS forecast
Marsh McLennan (NYSE:MMC) reported strong fourth-quarter results, with earnings per share (EPS) surpassing expectations and revenue showing robust growth. The company posted an adjusted EPS of $1. ...
Investing21d
Earnings call transcript: Aon PLC's Q4 2024 shows revenue growth, stock dips
Aon (NYSE:AON) PLC reported its fourth-quarter 2024 earnings, revealing a slight miss on revenue forecasts but surpassing earnings per share (EPS) expectations. The company's stock experienced a minor ...
Frontiers3mon
Causal association between plasma metabolites and diverse autoimmune diseases: a two-sample bidirectional mendelian randomization study
Background: Autoimmune diseases (ADs) are a category of conditions characterized by misrecognition of autologous tissues and organs by the immune system, leading to severe impairment of patients’ ...
Frontiers2y
Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells
Recombinant antibodies are rapidly developing therapeutic agents; approximately 40 novel antibody molecules enter clinical trials each year, most of which are produced from Chinese hamster ovary (CHO) ...